The best strategies for executing two-a-day threshold sessions without overdoing it. And the workouts to get you started.
IV delivery of VY1706, a CNS penetrant AAV gene therapy for AD, demonstrates compelling pharmacology and safety in a 3-month ...
Fascia – the body’s network of connective tissue – is at the very core of how we look, feel and move. How do we unlock its ...
18h
The Lost Rules of Strength Training – What 100 Years of Lifting Can Teach You About Building Muscle
When we reach for a barbell and plates, ready our lifting straps while swigging a luminescent pre-workout, we pay little ...
Ad hoc announcement pursuant to Art. 53 LR A conference call will be held on April 28, 2026, at 14:00 CEST / 13:00 BST / 08:00 EDT. Details are at the end of this news release AGAMREE delivers ...
Weight is a crucial factor that makes riding a cruiser bike special. A major advantage of a big twin cruiser bike's heft is ...
Pratteln, Switzerland, April 28, 2026 - Santhera Pharmaceuticals (SIX: SANN) today announces its full year results for the year ended 31 December 2025.
After months of grassroots fundraising and community support, a Santa Cruz County family is receiving a life-changing mobility vehicle—made possible by the collective generosity of neighbors, local ...
These results underscore that fenebrutinib has potential as a high-efficacy oral treatment for RMS. Its unique mode of action may offer a differentiated profile by targeting dual drivers of MS within ...
About ENSPRYNG® (satralizumab) ENSPRYNG, which was developed by Chugai, a member of the Roche Group, is a humanised monoclonal antibody that targets interleukin-6 (IL-6) receptor activity. ENSPRYNG ...
Whenever there is a wound or infection, the body produces an inflammatory response. This is the body's first line of defense, ...
Q: I enjoy strength training and do it a few times a week. I’m also active in my daily life. But I don’t do cardio workouts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results